Regulators around the globe are requiring more data from pharmaceutical companies as part of their applications for new drugs. This, coupled with an increased focus on patient safety, is creating an environment that requires companies to be up to date on current regulations and guidelines issued by multiple regulatory authorities.
Noncompliance with current regulatory guidelines can put patients at risk, delay product launch, and even result in fines. An effective clinical compliance program can help achieve timely, efficient, and safe clinical trials that…
What is GCP?